The Golden Arrow Awards have become one of the more meaningful governance benchmarks in the Philippine corporate landscape, precisely because they are not a marketing exercise. Organized by the Institute of Corporate Directors, the awards evaluate companies against the ASEAN Corporate Governance Scorecard, a framework developed by the ASEAN Capital Markets Forum and the Asian Development Bank to assess board practices, shareholder rights, disclosure quality, and accountability structures. For a company to earn a Two-Golden Arrow rating three years running means it has consistently met a high bar across all those dimensions, not just in a single reporting cycle when it might have been trying harder.
For Filipino consumers, insurance governance is not an abstract concern. Insurance companies sit on pools of policyholder money that must be available when claims are filed — during a typhoon, a hospital admission, or a death in the family. Weak governance at an insurer can manifest as slow claim processing, opaque policy terms, or in extreme cases, insolvency that leaves policyholders scrambling. The SEC, as the primary regulator of insurance companies in the Philippines, has been tightening oversight in recent years, but governance ratings from independent bodies like the ICD provide an additional layer of accountability that complements regulatory compliance.
The broader context matters here too. The Philippines has had a string of high-profile governance failures in publicly listed companies over the past decade, from related-party transaction scandals to board capture by controlling families. The ICD and the SEC have both responded by pushing for more independent directors, better committee structures, and fuller disclosure. Companies that consistently score well on the ASEAN scorecard are signaling that they have internalized these standards rather than treating them as box-ticking exercises.
What to watch next is whether governance ratings translate into tangible business outcomes in the Philippine insurance sector. Historically, Filipino consumers have chosen insurance products based on agent relationships and brand familiarity rather than governance scores. If the ICD's work gains more visibility among the investing public and institutional buyers, it could create a genuine market incentive for insurers to compete on transparency and board quality, not just on product pricing. That shift would benefit policyholders across the board.